Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.

@article{Hcker2004SuccessfulWO,
  title={Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years.},
  author={Britta H{\"o}cker and Ulrike John and Christian Plank and Elke Wuehl and Lutz Thorsten Weber and Joachim Misselwitz and Wolfgang Rascher and Otto Mehls and Burkhard Toenshoff},
  journal={Transplantation},
  year={2004},
  volume={78 2},
  pages={228-34}
}
BACKGROUND Despite their numerous systemic side effects, glucocorticoids (steroids) still form a cornerstone in immunosuppressive regimens in pediatric renal transplant recipients. The addition of mycophenolate mofetil (MMF) to a cyclosporine A (CsA)-based immunosuppressive regimen after renal transplantation may allow steroid withdrawal and amelioration or avoidance of steroid-specific side effects. METHODS In a retrospective case-control study, covering a mean follow-up period of 46 +/- 2.3… CONTINUE READING